The United States diabetes market continues to grow driven by increasing obesity rates, sedentary lifestyles, and rising healthcare expenditure. Expanding insulin therapies, oral antidiabetic drugs, and glucose monitoring systems enhance disease management, supporting robust market growth across the country. https://www.imarcgroup.com/us-diabetes-market